LV13033B - Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplantant rejection - Google Patents
Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplantant rejection Download PDFInfo
- Publication number
- LV13033B LV13033B LVP-03-25A LV030025A LV13033B LV 13033 B LV13033 B LV 13033B LV 030025 A LV030025 A LV 030025A LV 13033 B LV13033 B LV 13033B
- Authority
- LV
- Latvia
- Prior art keywords
- methyl
- ccr1 receptor
- chloro
- receptor antagonist
- phenoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22205300P | 2000-07-31 | 2000-07-31 | |
US23128200P | 2000-09-08 | 2000-09-08 | |
US09/915,411 US6740636B2 (en) | 2000-07-31 | 2001-07-25 | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
Publications (1)
Publication Number | Publication Date |
---|---|
LV13033B true LV13033B (en) | 2004-02-20 |
Family
ID=27397025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-03-25A LV13033B (en) | 2000-07-31 | 2003-02-28 | Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplantant rejection |
Country Status (28)
Country | Link |
---|---|
US (1) | US6740636B2 (da) |
EP (1) | EP1305047B1 (da) |
JP (1) | JP2004530630A (da) |
KR (1) | KR20030048000A (da) |
CN (1) | CN1655818A (da) |
AT (1) | ATE330634T1 (da) |
AU (2) | AU2001278073B2 (da) |
BG (1) | BG107502A (da) |
BR (1) | BR0113140A (da) |
CA (1) | CA2417636A1 (da) |
CY (1) | CY1105321T1 (da) |
DE (1) | DE60120986T2 (da) |
DK (1) | DK1305047T3 (da) |
EE (1) | EE200300047A (da) |
ES (1) | ES2261447T3 (da) |
HR (1) | HRP20030121A2 (da) |
HU (1) | HUP0300686A3 (da) |
IL (1) | IL153933A0 (da) |
LV (1) | LV13033B (da) |
MX (1) | MXPA03000836A (da) |
NO (1) | NO20030475L (da) |
NZ (1) | NZ523688A (da) |
PL (1) | PL364521A1 (da) |
PT (1) | PT1305047E (da) |
SI (1) | SI21123A (da) |
SK (1) | SK1222003A3 (da) |
WO (1) | WO2002009762A2 (da) |
YU (1) | YU6703A (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1838957A (zh) * | 2003-08-22 | 2006-09-27 | 舍林股份公司 | 抑制趋化因子的哌嗪衍生物及其治疗心肌炎的用途 |
US7917195B2 (en) | 2004-03-05 | 2011-03-29 | Lifesciences Solutions LLC | Systems, methods and computer program products for heart monitoring |
US10499828B2 (en) * | 2004-03-05 | 2019-12-10 | Lifescience Solutions, Llc | System and method for heart monitoring |
US8103065B2 (en) * | 2006-01-05 | 2012-01-24 | Lifescience Solutions Llc | Assessment of medical conditions |
US20110009758A1 (en) * | 2009-07-10 | 2011-01-13 | Lifescience Solutions Llc | System and method for heart monitoring |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6323206B1 (en) | 1996-07-12 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
EA002146B1 (ru) | 1997-02-26 | 2001-12-24 | Пфайзер Инк. | Производные амида гетероарил-гексановой кислоты, их получение и их применение в качестве селективных ингибиторов связывания mip-1-альфа с его рецептором ccr1 |
US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
WO1999037619A1 (en) | 1998-01-21 | 1999-07-29 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
HUP0101320A3 (en) | 1998-01-21 | 2002-11-28 | Kyowa Hakko Kogyo Kk | Benzo- and pyridobenzoxepine and -benzazepine derivatives and use thereof |
AU752407B2 (en) | 1998-02-05 | 2002-09-19 | Pfizer Products Inc. | Novel dihydroxyhexanoic acid derivatives |
EP1000626A1 (en) | 1998-09-18 | 2000-05-17 | Applied Research Systems ARS Holding N.V. | Chemokine receptor antagonist and cyclosporin in combined therapy |
WO2000044365A1 (en) | 1999-01-29 | 2000-08-03 | Millennium Pharmaceuticals, Inc. | Methods for preventing graft rejection and ischemia-reperfusion injury |
-
2001
- 2001-07-25 US US09/915,411 patent/US6740636B2/en not_active Expired - Fee Related
- 2001-07-31 ES ES01956035T patent/ES2261447T3/es not_active Expired - Lifetime
- 2001-07-31 BR BR0113140-0A patent/BR0113140A/pt not_active IP Right Cessation
- 2001-07-31 SK SK122-2003A patent/SK1222003A3/sk unknown
- 2001-07-31 HU HU0300686A patent/HUP0300686A3/hu unknown
- 2001-07-31 PT PT01956035T patent/PT1305047E/pt unknown
- 2001-07-31 PL PL01364521A patent/PL364521A1/xx not_active Application Discontinuation
- 2001-07-31 MX MXPA03000836A patent/MXPA03000836A/es unknown
- 2001-07-31 NZ NZ523688A patent/NZ523688A/en unknown
- 2001-07-31 WO PCT/US2001/023862 patent/WO2002009762A2/en active IP Right Grant
- 2001-07-31 IL IL15393301A patent/IL153933A0/xx unknown
- 2001-07-31 SI SI200120045A patent/SI21123A/sl not_active IP Right Cessation
- 2001-07-31 KR KR10-2003-7001483A patent/KR20030048000A/ko not_active Application Discontinuation
- 2001-07-31 AU AU2001278073A patent/AU2001278073B2/en not_active Expired - Fee Related
- 2001-07-31 DK DK01956035T patent/DK1305047T3/da active
- 2001-07-31 CA CA002417636A patent/CA2417636A1/en not_active Abandoned
- 2001-07-31 EP EP01956035A patent/EP1305047B1/en not_active Expired - Lifetime
- 2001-07-31 DE DE60120986T patent/DE60120986T2/de not_active Expired - Fee Related
- 2001-07-31 EE EEP200300047A patent/EE200300047A/xx unknown
- 2001-07-31 CN CNA018138004A patent/CN1655818A/zh active Pending
- 2001-07-31 AU AU7807301A patent/AU7807301A/xx active Pending
- 2001-07-31 AT AT01956035T patent/ATE330634T1/de not_active IP Right Cessation
- 2001-07-31 YU YU6703A patent/YU6703A/sh unknown
- 2001-07-31 JP JP2002515314A patent/JP2004530630A/ja not_active Withdrawn
-
2003
- 2003-01-27 BG BG107502A patent/BG107502A/xx unknown
- 2003-01-30 NO NO20030475A patent/NO20030475L/no not_active Application Discontinuation
- 2003-02-19 HR HR20030121A patent/HRP20030121A2/hr not_active Application Discontinuation
- 2003-02-28 LV LVP-03-25A patent/LV13033B/en unknown
-
2006
- 2006-09-05 CY CY20061101266T patent/CY1105321T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE60120986T2 (de) | 2006-11-23 |
HUP0300686A3 (en) | 2005-03-29 |
EP1305047A2 (en) | 2003-05-02 |
BG107502A (en) | 2003-07-31 |
NO20030475D0 (no) | 2003-01-30 |
BR0113140A (pt) | 2003-06-24 |
NO20030475L (no) | 2003-03-28 |
HUP0300686A2 (hu) | 2003-08-28 |
SI21123A (sl) | 2003-08-31 |
PL364521A1 (en) | 2004-12-13 |
AU7807301A (en) | 2002-02-13 |
DK1305047T3 (da) | 2006-10-23 |
KR20030048000A (ko) | 2003-06-18 |
JP2004530630A (ja) | 2004-10-07 |
CN1655818A (zh) | 2005-08-17 |
ES2261447T3 (es) | 2006-11-16 |
IL153933A0 (en) | 2003-07-31 |
MXPA03000836A (es) | 2003-06-06 |
WO2002009762A2 (en) | 2002-02-07 |
SK1222003A3 (en) | 2003-09-11 |
ATE330634T1 (de) | 2006-07-15 |
EP1305047B1 (en) | 2006-06-21 |
EE200300047A (et) | 2004-10-15 |
CY1105321T1 (el) | 2010-03-03 |
CA2417636A1 (en) | 2002-02-07 |
US20020039997A1 (en) | 2002-04-04 |
HRP20030121A2 (en) | 2005-02-28 |
WO2002009762A3 (en) | 2003-01-09 |
NZ523688A (en) | 2005-04-29 |
AU2001278073B2 (en) | 2005-06-30 |
US6740636B2 (en) | 2004-05-25 |
YU6703A (sh) | 2006-05-25 |
PT1305047E (pt) | 2006-11-30 |
DE60120986D1 (de) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kopp et al. | Cellular and molecular mechanisms of cyclosporin nephrotoxicity. | |
Pothoulakis et al. | CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. | |
Vergnolle et al. | A role for proteinase-activated receptor–1 in inflammatory bowel diseases | |
US20080058252A1 (en) | Use of C5A receptor antagonist in the treatment of fibrosis | |
Wilkinson et al. | Interleukin‐lβ, tumor necrosis factor‐α, and LPS enhance calcium channel current in isolated vascidar smooth muscle cells of rat tail artery | |
Ouseph et al. | Multiple second messenger systems act sequentially to mediate rolipram-induced prolongation of prostaglandin E2-induced mechanical hyperalgesia in the rat | |
AU2001278073B2 (en) | Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection | |
US20040091477A1 (en) | Immunosuppresive compositions | |
AU2001278073A1 (en) | Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection | |
JP2006528208A (ja) | コンプリメント5a受容体阻害剤を使用する出血ショックの処置 | |
ZA200301642B (en) | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection. | |
EP2063908B1 (en) | Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection | |
EP1423166B1 (en) | Non-peptide ccr1 receptor antagonists for the treatment of progressive renal fibrosis | |
JP2004510694A (ja) | 免疫抑制性組成物 | |
LT5132B (lt) | Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti | |
Crawford et al. | Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds | |
AU2003215446B2 (en) | Use of C5a receptor antagonist in the treatment of fibrosis | |
Garaci et al. | Ultrastructural and functional changes of the mouse thymus following treatment with an antiserum specific for thymic epithelial cells | |
Thomson et al. | Rejection, the Immune Response, and the Influence of Cyclosporin A | |
AU2007200012A1 (en) | Immunosuppressive compositions comprising an immunophilin-binding compound and a gingkolide compound |